Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Glabellar Lines
Clinical trial NCT03736928 · COMPLETED
Trial details
- NCT number
- NCT03736928
- Sponsor
- Galderma R&D
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-26
- Primary completion
- 2019-12-09
- Enrollment
- 401
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.